Verona Pharma plc

Verona Pharma — Merger or Acquisition (July 2025)

7 slides from Verona Pharma's merger presentation, Jul 9, 2025

  1. Slide 1: Corporate Update July 9, 2025

    Corporate Update July 9, 2025 Nasdaq: VRNA | www.veronapharma.com

  2. Slide 2: Merck reaches a definitive agreement to acquire Verona

    Merck reaches a definitive agreement to acquire Verona ~$10B / $107 per ADS 2

  3. Slide 3: What does the timeline for this look like?

    What does the timeline for this look like? 3 July 9 th Announcement of Acquisition In the 4 th Quarter of 2025 What happens between announcing the acquisition and closing? • Business as usual for Verona • Hart - Scott - Rodino Antitrust Improvements Act Approval • Approval by Verona Pharma Sharehold

  4. Slide 4: What does this mean for you?

    What does this mean for you? 4 Business As Usual - We operate as Verona until the deal closes - Stay focused on your responsibilities What is our commitment to you? Clear & timely communication

  5. Slide 5: Additional Information and Where to Find It

    Additional Information and Where to Find It 5 In connection with the proposed transaction between Verona Pharma and Merck, Verona Pharma will file with the Securities and Exchange Commission (“SEC”) a proxy statement on Schedule 14A. Additionally, Verona Pharma may file other relevant materials with

  6. Slide 6: Participants in the Solicitation

    Participants in the Solicitation 6 Verona Pharma, Merck and certain of their directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of Verona Pharma in connection with the proposed transaction. Information about Verona Pharma’s director

  7. Slide 7: Forward Looking Statements

    Forward Looking Statements 7 This presentation includes “forward - looking statements” within the meaning of the safe harbor provisions of the U.S. Private Sec urities Litigation Reform Act of 1995, including with respect to the proposed acquisition of Verona Pharma, and readers are cautioned not to

Verona Pharma — Merger or Acquisition (July 2025) on 6ix